Parenteral Nutrition
Debunking Hyperkalemia Myths: What Clinicians Need to Know
H yperkalemia is a life-threatening electrolyte disturbance with significant implications for patient care. Despite its seriousness, several myths persist in clinical practice. In this article, we'll address these myths and provide evidence-based recommendations. Introduction to hyperkalemia Hyperkalemia affects 2.6-2.7% of the U.…
قراءة المزيد
Type-2 Diabetes
Don't use DIABETES as a CV risk equivalent
As a pharmacy doctor, you will see more consensus on using statins for diabetes patients. We all know the controversy about the ACC/AHA cholesterol guidelines that abandoned LDL goals and recommended specific statin doses instead. Now the American Diabetes Association is following suit and providing similar guidance on when to use a statin in diabetes patients. …
قراءة المزيد
Ulcer
Do all ICU patients need Stress Ulcer Prophylaxis?
Introduction ã…¡ Patients who are admitted to ICU may suffer from Stress Ulceration, which is the development of superficial ulcers in the upper gastrointestinal (GI) tract. This differs from the reactivation of chronic duodenal or gastric ulcers as it is caused by either hypersecretion of gastric acid or impaired mucosal protection. Thus, m…
قراءة المزيد
Nephrology and Urology
Erythropoietin (EPO) dosing in anemia of CKD
Erythropoiesis-stimulating agents (ESAs) like erythropoietin (EPO) are integral for managing anemia in chronic kidney disease (CKD) . The recommended initial EPO dosing varies based on the route of administration and the patient’s clinical situation. For subcutaneous (SC) administration, start with a dose ranging from 50 to 100 U/…
قراءة المزيد
Nonalcoholic Steatohepatitis
Resmetirom for Nonalcoholic Steatohepatitis (NASH)
Resmetirom ( Rezdiffra ) is set to become the first medication approved for treating nonalcoholic steatohepatitis (NASH) with fibrosis in adults . About 5% of adults in the US have NASH. You will start to hear NASH called metabolic dysfunction-associated steatohepatitis (MASH) to reflect its link with cardiometabolic risk factors (diabetes, dyslipidemia, obesity, etc…
قراءة المزيد
Oncology
Immunotherapy: A Promising Cancer Therapy
Overview ã…¡ Our immune system keeps us protected from many threats such as infectious bacteria, viruses, and cancer too. However, cancer cells have their own ways and tricks to skip our defense system. Immunotherapy helps the immune cells to overcome these tricks and destroy cancer cells, which makes it a promising approach to treating canc…
قراءة المزيد
Social Plugin